GenBody Rapid COVID-19 Ag Test
Digital
Neu
€67.30
Vorrätig
United States
0 Bewertungen
The GenBody COVID-19 Ag point-of-care test is a lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
Features & Benefits
FDA EUA Authorized rapid antigen test
Anterior nasal swab specimen collection for comfort
Identifies acute infection with a 92.31% sensitivity and 99.04% specificity
Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
Large manufacturing capacity and immediately available for distribution
For use in the Point-of-Care setting
Features & Benefits
FDA EUA Authorized rapid antigen test
Anterior nasal swab specimen collection for comfort
Identifies acute infection with a 92.31% sensitivity and 99.04% specificity
Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
Large manufacturing capacity and immediately available for distribution
For use in the Point-of-Care setting
The GenBody COVID-19 Ag point-of-care test is a lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
Features & Benefits
FDA EUA Authorized rapid antigen test
Anterior nasal swab specimen collection for comfort
Identifies acute infection with a 92.31% sensitivity and 99.04% specificity
Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
Large manufacturing capacity and immediately available for distribution
For use in the Point-of-Care setting
0 Kommentare
0 Geteilt
1KB Ansichten
0 Bewertungen
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian